Healthcare Brew

A newsletter designed to help you understand the healthcare sector. Receive the most recent news and valuable insights about the intricate healthcare landscape directly in your inbox, twice a week.

National

English

Newsletter (Digital)

Outlet metrics

Domain Authority

Ranking

Global

#458919

United States

#108845

Health/Medicine

#947

Traffic sources

Monthly visitors

Articles

As wearables become more popular, regulations protecting data are still lacking

1 week ago | healthcare-brew.com | Cassie McGrath

Are you wearing a smart watch or smart ring right now? How about smart glasses or a hearing aid? All these devices are considered wearables, and the market for them has grown exponentially in recent years—from $20 billion in 2015 to $109.3 billion in 2023. Some of the devices, like watches and rings, collect user health data such as heart rates and blood oxygen levels.
United lent money to providers following Change cyberattack. Now it wants it back

1 week ago | healthcare-brew.com | Cassie McGrath

It’s sniffles season. People with asthma commonly suffer from allergies, too. Help your patients understand their allergic triggers with ImmunoCAP™ Specific IgE blood tests. And with this lab ordering guide, providers can browse region-specific profiles to help patients identify local allergic triggers. Learn more.
Sycamore Partners’ plan to takeover Walgreens ‘incredibly risky,’ analyst says

1 week ago | healthcare-brew.com | Maia Anderson

Walgreens is entering its private company era with Sycamore Partners’s take-private deal, announced in early March, to buy it for at least $22 billion. While getting off the public market can have its perks, analysts say the Walgreens Boots Alliance deal with the private equity (PE) firm could be risky, as it saddles the retail pharmacy giant with a significant amount of debt.
Pharma tariffs are coming ‘very shortly.’ Experts weigh in on what that could look like

1 week ago | healthcare-brew.com | Cassie McGrath

Access hard-to-reach clinicians. With in-office visit restrictions, it can be difficult for pharma reps to connect with clinicians. Here’s the good news: Primary care clinicians are still seeking out the latest healthcare innovations. Pri-Med helps you connect with those hard-to-reach primary care clinicians, both digitally and in person. Read about it here. The pharmaceutical industry seemingly came out on top when President Donald Trump announced import tariffs on April 2.
CVS names 2 new execs amid turnaround strategy

2 weeks ago | healthcare-brew.com | Maia Anderson

CVS named two new executives to its leadership team as the company tries to bounce back from a year that saw its net income cut nearly in half. The retail pharmacy giant named UPS veteran Brian Newman as its new EVP and CFO and Press Ganey expert Amy Compton-Phillips as its new EVP and chief medical officer. Newman will take over the role on April 21 and Compton-Phillips starts on May 19, CVS announced on April 8.
Duchenne community mourns patient death, but largely stands behind Elevidys gene therapy

2 weeks ago | healthcare-brew.com | Caroline Catherman

Access hard-to-reach clinicians. With in-office visit restrictions, it can be difficult for pharma reps to connect with clinicians. Here’s the good news: Primary care clinicians are still seeking out the latest healthcare innovations. Pri-Med helps you connect with those hard-to-reach primary care clinicians, both digitally and in person. Read about it here.
Medicare, Medicaid won’t be required to cover GLP-1s for obesity, CMS says

2 weeks ago | healthcare-brew.com | Maia Anderson

The Centers for Medicare and Medicaid Services (CMS) won’t go forward with a Biden-era proposal that would’ve required the government payers to cover GLP-1 drugs for obesity. In an announcement on April 7, CMS listed Part D coverage of anti-obesity medications as one of several Biden administration proposals for the 2026 contract year to be scrapped. The agency didn’t give details on why it decided against GLP-1 coverage, but said it might revisit the issue later on.
Lake Nona Impact Forum: The biggest health event you’ve never heard of

2 weeks ago | healthcare-brew.com | Caroline Catherman

It’s sniffles season. People with asthma commonly suffer from allergies, too. Help your patients understand their allergic triggers with ImmunoCAP™ Specific IgE blood tests. And with this lab ordering guide, providers can browse region-specific profiles to help patients identify local allergic triggers. Learn more. When thinking of medical innovation hotspots, Boston, New York, or even Houston might come to mind.
Recall Roundup: FDA medical device recalls during March 2025

2 weeks ago | healthcare-brew.com | Caroline Catherman

Welcome to Recall Roundup, where we keep you updated on the FDA’s medical device recalls from the last month. Recalls range from making tweaks to pulling a device from the market altogether. First, the manufacturer takes action, then the FDA categorizes them from Class III (least dangerous) to Class I (most dangerous). The FDA posts a list of the most serious recalls on its website, along with early alerts for things that may be labeled Class I recalls later on.
Now that digital therapeutics have Medicare coverage, the real test begins

2 weeks ago | healthcare-brew.com | Caroline Catherman

Medication and therapy have long been the standard protocol for treating mental health conditions. But there’s a third option: your smartphone. In 2017, the FDA began clearing virtual tools to treat conditions like depression, attention-deficit/hyperactivity disorder (ADHD), insomnia, and substance use disorder.